Inverse agonism by Dmt-Tic analogues and H5 378, a naltrindole analogue

被引:25
作者
Labarre, M
Butterworth, J
St-Onge, S
Payza, K
Schmidhammer, H
Salvadori, S
Balboni, G
Guerrini, R
Bryant, SD
Lazarus, LH [1 ]
机构
[1] Natl Inst Environm Hlth Sci, LCBRA, Res Triangle Pk, NC 27709 USA
[2] AstraZeneca R&D, Dept Pharmacol, St Laurent, PQ H4S 1Z9, Canada
[3] Univ Innsbruck, Inst Pharmaceut Chem, A-6020 Innsbruck, Austria
[4] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[5] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[6] Univ Cagliari, Dept Toxicol, I-09126 Cagliari, Italy
关键词
Dmt-Tic; inverse agonism; antagonism;
D O I
10.1016/S0014-2999(00)00636-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potent delta-opioid receptor antagonist H-2',6-L-tyrosine(Dmt)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic-OH) exhibited partial inverse agonism (EC(50) = 6.35 nM, E(max) = - 18.87%) for [(35)S]GTP gamma S binding and H-Dmt-Tic-NH(2) was a neutral antagonist (no effect up to 30 mu M). In contrast N,N(CH(3))(2)-Dmt-Tic-NH(2) was a full inverse agonist (EC(50) = 2.66 nM, E(max) = -35.95%) similar to ICI 174864 ([N,N-diallyl-Tyr(1),Aib(2,3),Leu(5)]enkephaline) but with a 3.5-fold higher EC(50) In comparison, naltrindole was a neutral antagonist while its analogue HS 378 was a partial inverse agonist (E(max) = - 12.99%). (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:R1 / R3
页数:3
相关论文
共 8 条
[1]   Opioid diketopiperazines: Refinement of the delta opioid antagonist pharmacophore [J].
Bryant, SD ;
Balboni, G ;
Guerrini, R ;
Salvadori, S ;
Tomatis, R ;
Lazarus, LH .
BIOLOGICAL CHEMISTRY, 1997, 378 (02) :107-114
[2]   New δ-opioid antagonists as pharmacological probes [J].
Bryant, SD ;
Salvadori, S ;
Cooper, PS ;
Lazarus, LH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (02) :42-46
[3]   Design of δ-opioid peptide antagonists for emerging drug applications [J].
Lazarus, LH ;
Bryant, SD ;
Cooper, PS ;
Guerrini, R ;
Balboni, G ;
Salvadori, S .
DRUG DISCOVERY TODAY, 1998, 3 (06) :284-294
[4]   Further studies on the Dmt-Tic pharmacophore:: Hydrophobic substituents at the C-terminus endow δ antagonists to manifest μ agonism or μ antagonism [J].
Salvadori, S ;
Guerrini, R ;
Balboni, G ;
Bianchi, C ;
Bryant, SD ;
Cooper, PS ;
Lazarus, LH .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) :5010-5019
[5]   DELTA-OPIOIDMIMETIC ANTAGONISTS - PROTOTYPES FOR DESIGNING A NEW-GENERATION OF ULTRASELECTIVE OPIOID-PEPTIDES [J].
SALVADORI, S ;
ATTILA, M ;
BALBONI, G ;
BIANCHI, C ;
BRYANT, SD ;
CRESCENZI, O ;
GUERRINI, R ;
PICONE, D ;
TANCREDI, T ;
TEMUSSI, PA ;
LAZARUS, LH .
MOLECULAR MEDICINE, 1995, 1 (06) :678-689
[6]  
Sasaki Y, 1999, CHEM PHARM BULL, V47, P1506
[7]   Synthesis and biological evaluation of 14-alkoxymorphinans -: Part 15 -: Novel δ opioid receptor antagonists with high affinity and selectivity in the 14-alkoxy-substituted indolomorphinan series [J].
Schmidhammer, H ;
Krassnig, R ;
Greiner, E ;
Schütz, J ;
White, A ;
Berzetei-Gurske, IP .
HELVETICA CHIMICA ACTA, 1998, 81 (06) :1064-1069
[8]   Involvement of trp-284, val-296, and val-297 of the human delta-opioid receptor in binding of delta-selective ligands [J].
Valiquette, M ;
Vu, HK ;
Yue, SY ;
Wahlestedt, C ;
Walker, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18789-18796